Selank.
Selank is a synthetic heptapeptide analog of the endogenous tuftsin peptide with an added glycine-proline-lysine (Gly-Pro-Lys) sequence at the C-terminus. With the molecular formula C₄₆H₇₃N₁₃O₁₃ and a...
Lab Verified
Clinical Grade
PMID Cited
Mechanism of Action.
Published preclinical research has characterized the following molecular pathways and receptor interactions for Selank.
GABA-A Receptor
Selank binds to GABA-A receptors as an allosteric modulator, affecting receptor subunit composition and chloride channel conductance.
Cytokine Expression
Published research indicates Selank influences interleukin-6 expression and other inflammatory mediators in glial cell cultures.
Clinical Literature
Research review on Selank molecular characterization.
Preclinical studies have characterized the molecular properties and receptor binding profiles of Selank in standardized assay systems.
Selank structure-activity relationship analysis.
Structure-activity relationship studies have examined the functional domains and binding characteristics of Selank in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
Related Compounds.
CognitiveCerebrolysin
$83.00N/A (complex porcine peptide mixture) · Variable (low-MW neuropeptides ≤10,000 Da)
For in vitro research use only. Not for human consumption.
CognitiveDSIP
$48.00C35H48N10O15 · 848.82 g/mol
For in vitro research use only. Not for human consumption.
CognitiveEpitalon
$47.00C14H22N4O9 · 390.35 g/mol
For in vitro research use only. Not for human consumption.